[HTML][HTML] Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

GJAM Boon, N Rein, HJ Bogaard, YM Ende-Verhaar… - PloS one, 2020 - journals.plos.org
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

[HTML][HTML] Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

GJAM Boon, N van Rein, HJ Bogaard… - PLoS ONE, 2020 - ncbi.nlm.nih.gov
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

[PDF][PDF] Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

G Boon, R Nv, HJ Bogaard, YM Ende-Verhaar… - PLoS …, 2020 - pdfs.semanticscholar.org
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.

G Boon, N van Rein, HJ Bogaard, YM Ende-Verhaar… - Plos one, 2020 - europepmc.org
BACKGROUND: The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.

GJAM Boon, N Rein, HJ Bogaard… - PLoS …, 2020 - search.ebscohost.com
Background: The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

GJAM Boon, N van Rein, HJ Bogaard… - PloS …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

[引用][C] Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

GJAM Boon, N Rein, HJ Bogaard… - PLoS …, 2020 - ui.adsabs.harvard.edu
Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Quality of initial …

[PDF][PDF] Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

G Boon, R Nv, HJ Bogaard, YM Ende-Verhaar… - PLoS ONE, 2020 - scholar.archive.org
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

GJAM Boon, N van Rein, HJ Bogaard… - PLOS …, 2020 - researchinformation.amsterdamumc …
Background The pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

G Boon, N Rein, HJ Bogaard… - PLoS …, 2020 - scholarlypublications …
BackgroundThe pathophysiology of chronic thromboembolic pulmonary hypertension
(CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk …